TGF-β is able to bind to its receptors and activate downstream Smad proteins (Smad2 or Smad3) via phosphorylation and nuclear translocation [27], and studies have indicated that the TGF-β/Smad pathway is crucial in controlling HCC growth and progression [28]. The gene discussed is SMAD3; the disease is hepatocellular carcinoma.